Thrivent Financial Sells $147,749 in Gloo Holdings Shares
1h ago|4 min readStandard
Fazen Markets Editorial Desk
Collective editorial team · methodology
thrivent-financialgloo-holdings
Fazen Markets Editorial Desk
Collective editorial team · methodology
Trades XAUUSD 24/5 on autopilot. Verified Myfxbook performance. Free forever.
Risk warning: CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. The majority of retail investor accounts lose money when trading CFDs. Vortex HFT is informational software — not investment advice. Past performance does not guarantee future results.
Thrivent Financial Advisors LLC confirmed a sale of 18,224 shares in Gloo Holdings Ltd. on 12 June 2026, according to a disclosure filed with the Securities and Exchange Commission. The transaction was valued at $147,749 based on the stock's closing price that day. The firm now holds 1,134,378 shares in the specialty insurance holding company, reducing its stake by approximately 1.6%. The filing lists the address of record for shares as the Depository Trust Company, a standard custodian arrangement for institutional holdings.
Thrivent's sale marks a continuation of a trend in the insurance sector, where portfolio managers are actively rebalancing exposures following the Federal Reserve's June 2026 policy signal. The Fed held rates steady but revised its dot plot higher, projecting fewer cuts than anticipated, which pressures long-duration assets. This macro pivot has increased scrutiny on holding duration and credit risk within insurance investment portfolios.
Globally, insurers have been adjusting portfolios to manage capital efficiency under Solvency II and similar frameworks, often leading to pruning of smaller, less liquid positions. The comparable event occurred in May 2026 when The Vanguard Group trimmed its position in a peer, Assurant Inc., by $45 million. Institutional rotation out of financial services sub-sectors has been ongoing since the first quarter of 2026.
The immediate catalyst for Thrivent's specific sale likely relates to routine portfolio rebalancing and individual stock sizing. Gloo Holdings, with a market capitalization under $500 million, represents a micro-cap holding. Its relative size within a large institutional portfolio can trigger automated or discretionary trimming after periods of price stability or underperformance.
The sale price reflects Gloo Holdings' closing price of $8.11 per share on 12 June 2026. Thrivent's remaining stake is valued at approximately $9.2 million based on that closing price. The firm's ownership stake in Gloo Holdings decreased from about 9.68% to 9.52% of shares outstanding following the transaction. Gloo Holdings' stock has traded within a 52-week range of $7.05 to $9.40.
| Metric | Pre-Sale (approx.) | Post-Sale (approx.) |
|---|---|---|
| Thrivent's Shares Held | 1,152,602 | 1,134,378 |
| Stake Value at $8.11 | $9,347,602 | $9,199,805 |
| Percent of Shares Outstanding | 9.68% | 9.52% |
Gloo Holdings' year-to-date return of +0.5% lags the broader S&P 500 Financials Sector Index, which is up 4.2% over the same period. The stock's average daily trading volume over the past 30 days is 85,000 shares, making Thrivent's 18,224-share sale equivalent to over 21% of a typical day's liquidity.
The sale represents a modest negative signal for Gloo Holdings' near-term price action, introducing a known seller into a thin market. It may increase the bid-ask spread for the stock temporarily as market makers adjust liquidity provisions. The transaction's size, however, is not large enough to indicate a fundamental loss of confidence; it is more indicative of routine portfolio management.
Second-order effects could include increased attention on other micro-cap insurers held by large institutions, such as Safety Insurance Group or United Fire Group. These smaller-cap names could see elevated volatility if other funds follow suit with similar rebalancing trades. The flow is moving from concentrated, less liquid single-stock positions toward more liquid ETFs or larger-cap peers like Progressive Corp. or Allstate Corp., which offer similar sector exposure with far greater daily volume.
A counter-argument is that the sale is entirely non-fundamental and reflects Thrivent's internal cash needs or mandate constraints rather than a view on Gloo Holdings' business. The firm remains a significant holder with over 9.5% ownership, suggesting a continued long-term commitment. Positioning data from the Options Clearing Corporation shows no unusual activity in Gloo options, implying the broader market is not interpreting the sale as a major directional catalyst.
The next key catalyst for Gloo Holdings is its second-quarter 2026 earnings report, expected in late July or early August. Investors will monitor the combined ratio and net premiums written for signs of underwriting discipline or top-line growth. The stock's technical level to watch is the $7.80 support zone, a prior consolidation area from April 2026; a break below could trigger further selling.
For Thrivent, monitor the firm's next Form 13F filing, due by 14 August 2026, for a complete snapshot of its U.S. equity portfolio changes across all holdings. Sector-wide, the NAIC's upcoming capital modeling report, due for publication in Q3 2026, could influence insurer portfolio strategies further. If the 10-year Treasury yield sustains a move above 4.5%, pressure on insurance investment portfolios will intensify, potentially prompting more sales of longer-duration or credit-sensitive holdings.
For a retail investor, the sale is more a lesson in market mechanics than a fundamental signal. A single institutional sale, especially of this modest size relative to daily volume, rarely dictates a stock's long-term direction. Retail investors should focus on Gloo Holdings' upcoming earnings, underwriting margins, and management commentary rather than any single transaction. The sale does highlight the stock's low liquidity, meaning retail orders can have a disproportionate impact on price.
Thrivent Financial is a long-term, value-oriented investor, not a high-frequency trader. Its previous SEC filing for Gloo Holdings was in May 2025, when it reported a position increase. This sale fits a pattern of periodic, small adjustments rather than a strategic exit. Compared to its activity in larger holdings like Microsoft or Johnson & Johnson, Thrivent trades Gloo far less frequently due to the position's smaller size and the challenges of trading a low-volume stock.
Historically, rising interest rates present a mixed picture for insurers. On one hand, they boost investment income from new bond purchases. On the other, they pressure the market value of existing bond portfolios and can increase policy lapse rates. The last sustained rising rate cycle from 2016 to 2018 saw the S&P 500 Insurance Index underperform the broader S&P 500 by approximately 300 basis points annually. Specialty insurers like Gloo, with shorter-duration asset portfolios, are often less sensitive to rate moves than life insurers.
Thrivent's sale is a routine portfolio adjustment, not a signal to abandon a $9 million position in Gloo Holdings.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. CFD trading carries high risk of capital loss.
Vortex HFT is our free MT4/MT5 Expert Advisor. Verified Myfxbook performance. No subscription. No fees. Trades 24/5.
Trade 800+ global stocks & ETFs
Start TradingSponsored
Open a demo account in 30 seconds. No deposit required.
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.